New MDA Grant Will Help Develop FA Drug

Repligen Corp. is proceeding with development of an experimental compound to treat Friedreich's ataxia, with help from a new MDA grant.
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.